It’s important to get this out of the way first: hyperbaric oxygen therapy is not a treatment for MS. I’m sure you’re aware by now that there’s no treatment. Hyperbaric oxygen treatment helps patients by stabilising their condition and enhancing their quality of life.
Hyperbaric Oxygen Therapy Symptom
Hyperbaric oxygen therapy has been shown to enhance symptom severity and functional ability in many persons with multiple sclerosis. Patients have experienced less ataxia, numbness in their fingers and hands, better balance, expanded vision, increased focus and less discomfort, weakness, and dizziness. Bladder and bowel diseases exhibit a high rate of reversibility and, in many cases, improvement is possible.
Vasoconstriction
Vasoconstriction, a side effect of hyperbaric oxygen therapy, helps the leaky, dilated blood vessels typical of multiple sclerosis shrink back to normal size. In addition to preventing the death of nerve cells, hyperbaric therapy lessens the edoema caused by a buildup of fluids inside the body. Vasoconstriction can be induced by medication, however this is usually accompanied by a decrease in tissue oxygenation.
The body’s wounded tissues, in particular, need oxygen to speed up and enhance the healing process. Multiple sclerosis is characterised by inflammation, and new study from the University of Dundee in Scotland has found that tissue swelling greatly reduces oxygen transfer. During a “MS flair,” they found that there is a drastic deficiency of oxygen in the affected areas. Then, when it’s most important for oxygen to enter the tissues to minimise swelling and assist prevent scarring or plaque formation, not enough oxygen gets there.
Medical Studies About Hyperbaric Oxygen Therapy
Medical studies conducted all over the world using hyperbaric oxygen have shown remarkable success in treating multiple sclerosis during the past two decades. Many European countries have adopted HBOT therapy as a standard part of their MS treatment plans. Nearly the past decade, over 10,000 people with multiple sclerosis in Britain have benefited from hyperbaric oxygen therapy at one of the more than 60 MS National Therapy Centres.
As soon as possible, ideally before irreparable lesions have formed, hyperbaric oxygen therapy should begin. This does not rule out the possibility of benefit for people with progressive forms of MS, but it does indicate that time is a factor.
Despite the fact that some of the individuals in the trials had more advanced cases of MS, the overall outcomes were highly promising.
Private Hyperbaric oxygen therapy for multiple sclerosis showed significant objective benefits in 70% of patients, according to a new study published in the respected New England Journal of Medicine. Almost 90% of patients who improved while receiving hyperbaric oxygen therapy kept their gains a full year after treatment finished.
